CNIPA Releases Patent Linkage Decisions, Paving Way for Generic Drugs in China
The China National Intellectual Property Administration (CNIPA) has released the latest batch of completed patent...
Patents
SMPA Suspends Procurement of Levornidazole by Warrant Pharmaceutical Over IP Concerns
Shanghai’s Sunshine Medical Procurement All-in-One (SMPA) has released a notification to suspend the procurement status...
Junshi Biosciences Challenges Alynlam’s PCSK9 siRNA Patent with CNIPA
Junshi Biosciences (SHA: 688180) is reportedly taking steps to challenge a key patent held by...
Huadong Medicine’s Patent Challenge Against Novo Nordisk’s Ozempic Heads to Hearing
February 23 will mark the oral hearing phase for the patent challenge case brought by...
Zhejiang Suspends Generic Nesina Trading Due to IP Disputes
Zhejiang’s Provincial Center for Drug & Medical Device Procurement has issued a notification suspending the...
Suzhou Thery’s Generic Nilotinib Approved by China’s NMPA
China-based Suzhou Thery Pharmaceutical Inc. has announced that the National Medical Products Administration (NMPA) has...
NHSA and CNIPA Issue Opinions on Strengthening IP Protection in Drug Procurement
The National Healthcare Security Administration (NHSA) and the China National Intellectual Property Administration (CNIPA) have...
Hainan Shuangcheng Files Paragraph IV Patent Declaration for Paclitaxel, Albumin-Bound
China’s Hainan Shuangcheng Pharmaceutical Co., Ltd (SHE: 002693) has announced a Paragraph IV patent declaration...
Shaanxi Panlong Receives Patents for Coronavirus 3CL Protease Inhibitor
China-based Shaanxi Panlong Pharmaceutical Group Co., Ltd (SHE: 002864) has announced receiving two patents (US11518759B1,...
Ascletis Pharma Receives USPTO Notice for ASC10 Patent
China-based Ascletis Pharma Inc. (HKG: 1672) has announced receiving the Notice of Issuance from the...
FibroGen Sues Former Employees and Two Pharma Firms for Trade Secret Theft
US-based FibroGen Inc. has filed a lawsuit against two former employees, Liu Dong and Deng...
Fujian Cosunter Receives Multiple Patents for Cancer and Hepatitis Drugs
China-based Fujian Cosunter Pharmaceutical Co., Ltd (SHE: 300436) has announced the receipt of multiple patents...
Shanghai SMPA Suspends HEC’s Linagliptin Procurement Over Patent Infringement
The Shanghai Sunshine Medical Procurement All-in-One (SMPA) platform has revealed that it has suspended the...
CSPC’s Generic Xofluza Gains NMPA Approval Amid Roche Patent Dispute
China-based CSPC Pharmaceutical Group Co., Ltd (HKG: 1093) has obtained market approval from the National...
Guangdong Zhongsheng Receives USPTO Patent for FGFR4 Inhibitor ZSP1241
China-based Guangdong Zhongsheng Pharmaceutical Co., Ltd (SHE: 002317) has announced receiving a patent award from...
Supreme People’s Court Rules Against Chugai in China’s First Patent Linkage Case
China’s Supreme People’s Court has delivered its verdict in the nation’s first patent linkage dispute,...
Boehringer Ingelheim Wins Patent Infringement Ruling Against HEC Over Trajenta
The China National Intellectual Property Administration (CNIPA) has ruled in favor of German pharmaceutical giant...